✦ LIBER ✦

A phase II study with a 4-drug combination chemotherapy in advanced Non-Small Cell Lung Cancer (NSCLC)

Book ID: 123002186
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 140 KB
Volume: 7
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(91)91842-Y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with carboplati

Combination chemotherapy with carboplatin (CBDCA), docetaxel (DOC) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC). A phase II study

✍ Pectasides, D.; Aspropotamitis, A.; Halikia, A.; Visvikis, A.; Antoniou, F.; Kal 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Alternating chemotherapy in advanced non

Alternating chemotherapy in advanced non-small cell lung cancer: A phase II study

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 152 KB

1064 Gemcitabine-cisplatin combination i

1064 Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study

✍ Crinò, L.; Seagliotti, G.; Marangolo, M.; Figoli, F.; Clerici, M.; De Marinis, F 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 160 KB

5 Brachytherapy plus chemotherapy in adv

5 Brachytherapy plus chemotherapy in advanced non small cell lung cancer (NSCLC) phase II trial

✍ Grigorescu, A.; Bacinschi, X.; Radoi, S.; Ciocaltei, V. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 152 KB

A phase II study of docetaxel and vinore

A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer

✍ J Bennouna; A Monnier; A Rivière; B Milleron; E Lemarie; V Trillet-Lenoir; K Sou 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Urokinase combination chemotherapy in sm

Urokinase combination chemotherapy in small cell lung cancer. A phase II study

✍ F. A. Calvo; O. F. Hidalgo; F. Gonzalez; J. Rebollo; S. Martin Algarra; D. Ortiz 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 770 KB

## Background and methods: Fifty-one patients with small cell lung cancer (sclc) were treated with alternating urokinase (uk)-cyclophosphamide-doxorubicin (adriamycin, adria laboratories, columbus, oh)-vincristine and cisplatin-etoposide-vincristine. uk was given as a loading dose of 3000 microgram